{"transactions":[{"id":703425,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"officer":true,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Performance Right","published_at":"2026-07-24T22:10:50.000Z","date":"2026-07-22","kind":"exercise","planned":false,"acquired":false,"shares":22768,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On July 19, 2023, the reporting person received a target grant of 22,768 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2024, 2025 and 2026 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 6,466 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On July 19, 2023, the reporting person received a target grant of 22,768 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2024, 2025 and 2026 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 6,466 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On July 19, 2023, the reporting person received a target grant of 22,768 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2024, 2025 and 2026 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 6,466 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":22768},"source":{"system":"sec-edgar","filing":"0001140361-26-029632","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126029632/form4.xml","form_type":"4"}},{"id":703424,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"officer":true,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2026-07-24T22:10:50.000Z","date":"2026-07-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":2330,"price":13.82,"value":32200.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 2,330 shares of Common Stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 19, 2023."}],"balance_after":108676,"source":{"system":"sec-edgar","filing":"0001140361-26-029632","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126029632/form4.xml","form_type":"4"}},{"id":703423,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"officer":true,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2026-07-24T22:10:50.000Z","date":"2026-07-22","kind":"exercise","planned":false,"acquired":true,"shares":6466,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This acquisition of 6,466 shares of Common Stock (\"Common Stock\") of AngioDynamics, Inc. (\"AngioDynamics\") represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 19, 2023."}],"balance_after":111006,"source":{"system":"sec-edgar","filing":"0001140361-26-029632","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126029632/form4.xml","form_type":"4"}},{"id":704632,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"officer":true,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Performance Right","published_at":"2026-07-23T00:06:03.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":16081,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."}],"balance_after":16081,"derivative":{"underlying":"Common Stock","underlying_shares":16081},"source":{"system":"sec-edgar","filing":"0001140361-26-029331","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126029331/form4.xml","form_type":"4"}},{"id":704631,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"officer":true,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2026-07-23T00:06:03.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":16081,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 16,081 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. represents 16,081 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 15, 2027, such that 25% of the restricted stock units will vest on each of July 15, 2027, 2028, 2029 and 2030."}],"balance_after":104540,"source":{"system":"sec-edgar","filing":"0001140361-26-029331","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126029331/form4.xml","form_type":"4"}},{"id":705124,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"officer":true,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2026-07-22T00:10:40.000Z","date":"2026-07-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":359,"price":13.71,"value":4921.89,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The exempt disposition of 359 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 20, 2022."}],"balance_after":88459,"source":{"system":"sec-edgar","filing":"0001140361-26-029176","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126029176/form4.xml","form_type":"4"}},{"id":705123,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"officer":true,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2026-07-22T00:10:40.000Z","date":"2026-07-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":1112,"price":13.51,"value":15023.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 1,112 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 17, 2024."}],"balance_after":88818,"source":{"system":"sec-edgar","filing":"0001140361-26-029176","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126029176/form4.xml","form_type":"4"}},{"id":705122,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"officer":true,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2026-07-22T00:10:40.000Z","date":"2026-07-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":2367,"price":14.14,"value":33469.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 2,367 shares of common stock of AngioDynamics, Inc. (\"AngioDynamics\") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 16, 2025."}],"balance_after":89930,"source":{"system":"sec-edgar","filing":"0001140361-26-029176","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036126029176/form4.xml","form_type":"4"}},{"id":1083287,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"officer":true,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2025-07-22T22:22:16.000Z","date":"2025-07-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":395,"price":8.99,"value":3551.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The exempt disposition of 395 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 21, 2021."}],"balance_after":92297,"source":{"system":"sec-edgar","filing":"0001140361-25-026796","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036125026796/form4.xml","form_type":"4"}},{"id":1083286,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"officer":true,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2025-07-22T22:22:16.000Z","date":"2025-07-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":359,"price":8.69,"value":3119.71,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 359 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 20, 2022."}],"balance_after":92692,"source":{"system":"sec-edgar","filing":"0001140361-25-026796","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036125026796/form4.xml","form_type":"4"}},{"id":1083285,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"officer":true,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2025-07-22T22:22:16.000Z","date":"2025-07-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":1025,"price":8.69,"value":8907.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 1,025 shares of common stock of AngioDynamics, Inc. (\"AngioDynamics\") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 19, 2023."}],"balance_after":93051,"source":{"system":"sec-edgar","filing":"0001140361-25-026796","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036125026796/form4.xml","form_type":"4"}},{"id":1084579,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"officer":true,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Performance Right","published_at":"2025-07-18T22:06:21.000Z","date":"2025-07-16","kind":"grant","planned":false,"acquired":true,"shares":26268,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."}],"balance_after":26268,"derivative":{"underlying":"Common Stock","underlying_shares":26268},"source":{"system":"sec-edgar","filing":"0001140361-25-026461","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036125026461/form4.xml","form_type":"4"}},{"id":1084578,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"officer":true,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2025-07-18T22:06:21.000Z","date":"2025-07-16","kind":"grant","planned":false,"acquired":true,"shares":26268,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 26,268 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. represents 26,268 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 16, 2026, such that 25% of the restricted stock units will vest on each of July 16, 2026, 2027, 2028 and 2029."}],"balance_after":94076,"source":{"system":"sec-edgar","filing":"0001140361-25-026461","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036125026461/form4.xml","form_type":"4"}},{"id":1442661,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"officer":true,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Performance Right","published_at":"2024-08-03T01:48:43.000Z","date":"2024-07-17","kind":"exercise","planned":false,"acquired":true,"shares":8777,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On July 21, 2021, the reporting person received a target grant of 8,777 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2022, 2023 and 2024 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 6,600 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On July 21, 2021, the reporting person received a target grant of 8,777 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2022, 2023 and 2024 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 6,600 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On July 21, 2021, the reporting person received a target grant of 8,777 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2022, 2023 and 2024 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 6,600 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8777},"source":{"system":"sec-edgar","filing":"0001140361-24-035598","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036124035598/form4.xml","form_type":"4"}},{"id":1442660,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"officer":true,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2024-08-03T01:48:43.000Z","date":"2024-07-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":2379,"price":7.4,"value":17604.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 2,379 shares of Common Stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 21, 2021."}],"balance_after":67808,"source":{"system":"sec-edgar","filing":"0001140361-24-035598","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036124035598/form4.xml","form_type":"4"}},{"id":1442659,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"officer":true,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2024-08-03T01:48:43.000Z","date":"2024-07-17","kind":"exercise","planned":false,"acquired":true,"shares":6600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This acquisition of 6,600 shares of Common Stock (\"Common Stock\") of AngioDynamics, Inc. (\"AngioDynamics\") represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 21, 2021."}],"balance_after":70187,"source":{"system":"sec-edgar","filing":"0001140361-24-035598","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036124035598/form4.xml","form_type":"4"}},{"id":1448621,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"officer":true,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2024-07-26T01:00:21.000Z","date":"2024-07-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":395,"price":7.13,"value":2816.35,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 395 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares of underlying restricted stock units granted to the reporting person on July 21, 2021."}],"balance_after":63587,"source":{"system":"sec-edgar","filing":"0001140361-24-034272","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036124034272/form4.xml","form_type":"4"}},{"id":1448620,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"officer":true,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2024-07-26T01:00:21.000Z","date":"2024-07-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":359,"price":7.13,"value":2559.67,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 359 shares of common stock of AngioDynamics, Inc. (\"AngioDynamics\") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 20, 2022."}],"balance_after":63982,"source":{"system":"sec-edgar","filing":"0001140361-24-034272","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036124034272/form4.xml","form_type":"4"}},{"id":1449852,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"officer":true,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2024-07-23T10:01:28.000Z","date":"2024-07-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":1025,"price":7.18,"value":7359.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 1,025 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 19, 2023."}],"balance_after":64341,"source":{"system":"sec-edgar","filing":"0001140361-24-033783","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036124033783/form4.xml","form_type":"4"}},{"id":1451111,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"officer":true,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-07-19T21:18:34.000Z","date":"2024-07-17","kind":"grant","planned":false,"acquired":true,"shares":24240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These stock options vest in four equal annual installments beginning on July 17, 2025, such that 25% of the options will vest on each of July 17, 2025, 2026, 2027 and 2028."}],"balance_after":24240,"derivative":{"exercise_price":7.4,"exercise_date":"2025-07-17","expiration_date":"2034-07-17","underlying":"Common Stock","underlying_shares":24240},"source":{"system":"sec-edgar","filing":"0001140361-24-033637","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036124033637/form4.xml","form_type":"4"}},{"id":1451110,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"officer":true,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Performance Right","published_at":"2024-07-19T21:18:34.000Z","date":"2024-07-17","kind":"grant","planned":false,"acquired":true,"shares":24699,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."}],"balance_after":24699,"derivative":{"underlying":"Common Stock","underlying_shares":24699},"source":{"system":"sec-edgar","filing":"0001140361-24-033637","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036124033637/form4.xml","form_type":"4"}},{"id":1451109,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"officer":true,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2024-07-19T21:18:34.000Z","date":"2024-07-17","kind":"grant","planned":false,"acquired":true,"shares":12350,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 12,350 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. represents 12,350 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 17, 2025, such that 25% of the restricted stock units will vest on each of July 17, 2025, 2026, 2027 and 2028."}],"balance_after":65366,"source":{"system":"sec-edgar","filing":"0001140361-24-033637","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036124033637/form4.xml","form_type":"4"}},{"id":1775301,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"officer":true,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Performance Right","published_at":"2023-09-22T01:12:26.000Z","date":"2023-07-19","kind":"exercise","planned":false,"acquired":false,"shares":13453,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On July 14, 2020, the reporting person received a target grant of 13,453 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2021, 2022 and 2023. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics as determined by the compensation committee. Based on performance over the period, 8,610 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On July 14, 2020, the reporting person received a target grant of 13,453 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2021, 2022 and 2023. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics as determined by the compensation committee. Based on performance over the period, 8,610 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On July 14, 2020, the reporting person received a target grant of 13,453 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2021, 2022 and 2023. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics as determined by the compensation committee. Based on performance over the period, 8,610 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":13453},"source":{"system":"sec-edgar","filing":"0001140361-23-044835","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036123044835/form4.xml","form_type":"4/A","original_submission_date":"2023-07-26"}},{"id":1775300,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"officer":true,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2023-09-22T01:12:26.000Z","date":"2023-07-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":3103,"price":8.92,"value":27678.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 3,103 shares of Common Stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 14, 2020."}],"balance_after":53016,"source":{"system":"sec-edgar","filing":"0001140361-23-044835","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036123044835/form4.xml","form_type":"4/A","original_submission_date":"2023-07-26"}},{"id":1775299,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"officer":true,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2023-09-22T01:12:26.000Z","date":"2023-07-19","kind":"exercise","planned":false,"acquired":true,"shares":8610,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This acquisition of 8,610 shares of Common Stock (\"Common Stock\") of AngioDynamics, Inc. (\"AngioDynamics\") represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 14, 2020."}],"balance_after":56119,"source":{"system":"sec-edgar","filing":"0001140361-23-044835","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036123044835/form4.xml","form_type":"4/A","original_submission_date":"2023-07-26"}},{"id":1822740,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"officer":true,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Performance Right","published_at":"2023-07-27T01:32:38.000Z","date":"2023-07-19","kind":"exercise","planned":false,"acquired":false,"shares":13453,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On July 14, 2020, the reporting person received a target grant of 30,242 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2021, 2022 and 2023 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 8,769 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On July 14, 2020, the reporting person received a target grant of 30,242 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2021, 2022 and 2023 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 8,769 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On July 14, 2020, the reporting person received a target grant of 30,242 performance share units. Between 0% and 200% of the target number was to be earned based on achievement of pre-determined performance metrics for fiscal years 2021, 2022 and 2023 as determined by the compensation committee. In addition, 20% of the total shares earned could be awarded (or cancelled) based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics. Based on performance over the period, 8,769 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":13453},"source":{"system":"sec-edgar","filing":"0001140361-23-036320","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036123036320/form4.xml","form_type":"4"}},{"id":1822739,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"officer":true,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2023-07-27T01:32:38.000Z","date":"2023-07-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":1404,"price":8.92,"value":12523.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 1,404 shares of Common Stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 14, 2020."}],"balance_after":50005,"source":{"system":"sec-edgar","filing":"0001140361-23-036320","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036123036320/form4.xml","form_type":"4"}},{"id":1822738,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"officer":true,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2023-07-27T01:32:38.000Z","date":"2023-07-19","kind":"exercise","planned":false,"acquired":true,"shares":3900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This acquisition of 3,900 shares of Common Stock (\"Common Stock\") of AngioDynamics, Inc. (\"AngioDynamics\") represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 14, 2020."}],"balance_after":51409,"source":{"system":"sec-edgar","filing":"0001140361-23-036320","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036123036320/form4.xml","form_type":"4"}},{"id":1823426,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"officer":true,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2023-07-25T23:06:54.000Z","date":"2023-07-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":395,"price":8.65,"value":3416.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 395 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 21, 2021."}],"balance_after":47509,"source":{"system":"sec-edgar","filing":"0001140361-23-036116","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036123036116/form4.xml","form_type":"4"}},{"id":1823425,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"officer":true,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2023-07-25T23:06:54.000Z","date":"2023-07-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":359,"price":8.74,"value":3137.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 359 shares of common stock of AngioDynamics, Inc. (\"AngioDynamics\") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 20, 2022."}],"balance_after":47904,"source":{"system":"sec-edgar","filing":"0001140361-23-036116","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036123036116/form4.xml","form_type":"4"}},{"id":1824708,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"officer":true,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-07-22T01:11:13.000Z","date":"2023-07-19","kind":"grant","planned":false,"acquired":true,"shares":23561,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These stock options vest in four equal annual installments beginning on July 19, 2024, such that 25% of the options will vest on each of July 19, 2024, 2025, 2026 and 2027."}],"balance_after":23561,"derivative":{"exercise_price":8.92,"exercise_date":"2024-07-19","expiration_date":"2033-07-19","underlying":"Common Stock","underlying_shares":23561},"source":{"system":"sec-edgar","filing":"0001140361-23-035730","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036123035730/form4.xml","form_type":"4"}},{"id":1824707,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"officer":true,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Performance Right","published_at":"2023-07-22T01:11:13.000Z","date":"2023-07-19","kind":"grant","planned":false,"acquired":true,"shares":22768,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned  over a three-year performance period in accordance with performance metrics as determined by the compensation committee (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)). Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned  over a three-year performance period in accordance with performance metrics as determined by the compensation committee (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)). Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned  over a three-year performance period in accordance with performance metrics as determined by the compensation committee (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)). Any shares that do not vest at the end of the performance period will be forfeited."}],"balance_after":22768,"derivative":{"underlying":"Common Stock","underlying_shares":22768},"source":{"system":"sec-edgar","filing":"0001140361-23-035730","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036123035730/form4.xml","form_type":"4"}},{"id":1824706,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"officer":true,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2023-07-22T01:11:13.000Z","date":"2023-07-19","kind":"grant","planned":false,"acquired":true,"shares":11384,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 11,384 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. represents 11,384 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 19, 2024, such that 25% of the restricted stock units will vest on each of July 19, 2024, 2025, 2026 and 2027."}],"balance_after":48263,"source":{"system":"sec-edgar","filing":"0001140361-23-035730","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036123035730/form4.xml","form_type":"4"}},{"id":1827690,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"officer":true,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2023-07-19T00:13:31.000Z","date":"2023-07-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":279,"price":9.56,"value":2667.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 279 shares of common stock of AngioDynamics was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 17, 2019."}],"balance_after":36879,"source":{"system":"sec-edgar","filing":"0001140361-23-035085","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036123035085/form4.xml","form_type":"4"}},{"id":1827689,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"officer":true,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2023-07-19T00:13:31.000Z","date":"2023-07-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":596,"price":9.63,"value":5739.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 596 shares of common stock of AngioDynamics, Inc. (\"AngioDynamics\") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 14, 2020."}],"balance_after":37158,"source":{"system":"sec-edgar","filing":"0001140361-23-035085","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036123035085/form4.xml","form_type":"4"}},{"id":2203178,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Non- Qualified Stock Option (right to buy)","published_at":"2022-07-22T22:44:56.000Z","date":"2022-07-20","kind":"grant","acquired":true,"shares":9341,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These stock options vest in four equal annual installments beginning on July 20, 2023, such that 25% of the options will vest on each of July 20, 2023, 2024, 2025 and 2026."}],"balance_after":9341,"derivative":{"exercise_price":21.53,"exercise_date":"2023-07-20","expiration_date":"2032-07-20","underlying":"Common Stock","underlying_shares":9341},"source":{"system":"sec-edgar","filing":"0001567619-22-014377","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761922014377/doc1.xml","form_type":"4"}},{"id":2203177,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Performance Right","published_at":"2022-07-22T22:44:56.000Z","date":"2022-07-20","kind":"grant","acquired":true,"shares":7974,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period (with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate)) in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."}],"balance_after":7974,"derivative":{"underlying":"Common Stock","underlying_shares":7974},"source":{"system":"sec-edgar","filing":"0001567619-22-014377","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761922014377/doc1.xml","form_type":"4"}},{"id":2203176,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2022-07-22T22:44:56.000Z","date":"2022-07-20","kind":"grant","acquired":true,"shares":3987,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The acquisition of 3,987 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. represents 3,987 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 20, 2023, such that 25% of the restricted stock units will vest on each of July 20, 2023, 2024, 2025 and 2026."}],"balance_after":37754,"source":{"system":"sec-edgar","filing":"0001567619-22-014377","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761922014377/doc1.xml","form_type":"4"}},{"id":2209133,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Performance Right","published_at":"2022-07-11T10:17:49.000Z","date":"2022-07-07","kind":"exercise","acquired":false,"shares":6195,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On October 16, 2019, the reporting person received a target grant of 6,195 performance share units. Between 0% and 200% of the target number was to be earned based equally on revenue growth and adjusted earnings per share growth over a three-year performance period with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate). Based on performance over the period, 3,104 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On October 16, 2019, the reporting person received a target grant of 6,195 performance share units. Between 0% and 200% of the target number was to be earned based equally on revenue growth and adjusted earnings per share growth over a three-year performance period with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate). Based on performance over the period, 3,104 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On October 16, 2019, the reporting person received a target grant of 6,195 performance share units. Between 0% and 200% of the target number was to be earned based equally on revenue growth and adjusted earnings per share growth over a three-year performance period with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate). Based on performance over the period, 3,104 shares of Common Stock were issued to the reporting person under this grant and the remaining shares were forfeited."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6195},"source":{"system":"sec-edgar","filing":"0001567619-22-013848","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761922013848/doc1.xml","form_type":"4"}},{"id":2209132,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2022-07-11T10:17:49.000Z","date":"2022-07-07","kind":"tax_withholding","acquired":false,"shares":1078,"price":20.54,"value":22142.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 1,078 shares of Common Stock to the Company was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on October 16, 2019."}],"balance_after":33767,"source":{"system":"sec-edgar","filing":"0001567619-22-013848","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761922013848/doc1.xml","form_type":"4"}},{"id":2209131,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2022-07-11T10:17:49.000Z","date":"2022-07-07","kind":"exercise","acquired":true,"shares":3104,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This acquisition of 3,104 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. (the \"Company\") represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on October 16, 2019."}],"balance_after":34845,"source":{"system":"sec-edgar","filing":"0001567619-22-013848","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761922013848/doc1.xml","form_type":"4"}},{"id":2456046,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-12-30T22:56:22.000Z","date":"2021-07-21","kind":"grant","acquired":true,"shares":11923,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On July 23, 2021, the reporting person filed a Form 4 to report, among other items, the granting of stock options of AngioDynamics, Inc., which contained an administrative error as to the exercise price of such options."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These stock options vest in four equal annual installments beginning on July 21, 2022, such that 25% of the options will vest on each of July 21, 2022, 2023, 2024 and 2025."}],"balance_after":11923,"derivative":{"exercise_price":26.49,"exercise_date":"2022-07-21","expiration_date":"2031-07-21","underlying":"Common Stock","underlying_shares":11923},"source":{"system":"sec-edgar","filing":"0001567619-21-022709","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761921022709/doc1.xml","form_type":"4/A","original_submission_date":"2021-07-23"}},{"id":2547000,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-10-06T22:39:20.000Z","date":"2021-10-05","kind":"exercise","acquired":false,"shares":10748,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options for one-fourth of the shares became exercisable on 7/27/2017, 7/27/2018, 7/27/2019 and 7/27/2020, respectively."}],"balance_after":0,"derivative":{"exercise_price":16.59,"exercise_date":"2020-07-27","expiration_date":"2023-07-25","underlying":"Common Stock","underlying_shares":10748},"source":{"system":"sec-edgar","filing":"0001567619-21-017999","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761921017999/doc1.xml","form_type":"4"}},{"id":2546999,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2021-10-06T22:39:20.000Z","date":"2021-10-05","kind":"sale","acquired":false,"shares":10748,"price":27.15,"value":291808.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $27.07 to $27.35, inclusive.  The reporting person has provided to AngioDynamics, Inc., and undertakes to provide to any security holder of AngioDynamics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 1."}],"balance_after":31741,"source":{"system":"sec-edgar","filing":"0001567619-21-017999","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761921017999/doc1.xml","form_type":"4"}},{"id":2546998,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2021-10-06T22:39:20.000Z","date":"2021-10-05","kind":"exercise","acquired":true,"shares":10748,"price":16.59,"value":178309.32,"ownership":{"direct":true},"balance_after":42489,"source":{"system":"sec-edgar","filing":"0001567619-21-017999","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761921017999/doc1.xml","form_type":"4"}},{"id":2597495,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Performance Right","published_at":"2021-08-18T11:11:31.000Z","date":"2021-08-12","kind":"exercise","acquired":false,"shares":7079,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"On July 18, 2018, the reporting person received a target grant of 7,079 performance share units. Between 0% and 200% of the target number was to be earned based on total shareholder return relative to a peer group of companies over a three-year performance period ending May 31, 2021. Based on performance over the period, 8,210 shares of Common Stock were issued to the reporting person under this grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On July 18, 2018, the reporting person received a target grant of 7,079 performance share units. Between 0% and 200% of the target number was to be earned based on total shareholder return relative to a peer group of companies over a three-year performance period ending May 31, 2021. Based on performance over the period, 8,210 shares of Common Stock were issued to the reporting person under this grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On July 18, 2018, the reporting person received a target grant of 7,079 performance share units. Between 0% and 200% of the target number was to be earned based on total shareholder return relative to a peer group of companies over a three-year performance period ending May 31, 2021. Based on performance over the period, 8,210 shares of Common Stock were issued to the reporting person under this grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7079},"source":{"system":"sec-edgar","filing":"0001567619-21-016025","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761921016025/doc1.xml","form_type":"4/A","original_submission_date":"2021-08-17"}},{"id":2597494,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2021-08-18T11:11:31.000Z","date":"2021-08-12","kind":"tax_withholding","acquired":false,"shares":3130,"price":27.29,"value":85417.7,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On August 17, 2021, the reporting person filed a Form 4 to report the vesting and settlement of performance share units and the sale of certain underlying shares of common stock (\"Common Stock\") of AngioDynamics, Inc. (the \"Company\"), which contained administrative errors as to the terms of the performance share units and the number of shares of Common Stock of the Company issued and sold."},{"field":"shares","element":"transactionShares","label":"F3","text":"The exempt disposition of 3,130 shares of Common Stock of the Company was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 18, 2018."}],"balance_after":31741,"source":{"system":"sec-edgar","filing":"0001567619-21-016025","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761921016025/doc1.xml","form_type":"4/A","original_submission_date":"2021-08-17"}},{"id":2597493,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2021-08-18T11:11:31.000Z","date":"2021-08-12","kind":"exercise","acquired":true,"shares":8210,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"On August 17, 2021, the reporting person filed a Form 4 to report the vesting and settlement of performance share units and the sale of certain underlying shares of common stock (\"Common Stock\") of AngioDynamics, Inc. (the \"Company\"), which contained administrative errors as to the terms of the performance share units and the number of shares of Common Stock of the Company issued and sold."},{"field":"shares","element":"transactionShares","label":"F2","text":"This acquisition of 8,210 shares of Common Stock of the Company represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 18, 2018."}],"balance_after":34871,"source":{"system":"sec-edgar","filing":"0001567619-21-016025","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761921016025/doc1.xml","form_type":"4/A","original_submission_date":"2021-08-17"}},{"id":2599655,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Performance Right","published_at":"2021-08-17T10:48:14.000Z","date":"2021-08-12","kind":"exercise","acquired":false,"shares":6195,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On October 16, 2019, the reporting person received a target grant of 6,195 performance share units. Between 0% and 200% of the target number was to be earned based equally on revenue growth and adjusted earnings per share growth over a three-year performance period with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate). Based on performance over the period, 2,395 shares of Common Stock were issued to the reporting person under this grant and the remaining performance share units were forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On October 16, 2019, the reporting person received a target grant of 6,195 performance share units. Between 0% and 200% of the target number was to be earned based equally on revenue growth and adjusted earnings per share growth over a three-year performance period with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate). Based on performance over the period, 2,395 shares of Common Stock were issued to the reporting person under this grant and the remaining performance share units were forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On October 16, 2019, the reporting person received a target grant of 6,195 performance share units. Between 0% and 200% of the target number was to be earned based equally on revenue growth and adjusted earnings per share growth over a three-year performance period with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate). Based on performance over the period, 2,395 shares of Common Stock were issued to the reporting person under this grant and the remaining performance share units were forfeited."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6195},"source":{"system":"sec-edgar","filing":"0001567619-21-015950","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761921015950/doc1.xml","form_type":"4"}},{"id":2599654,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2021-08-17T10:48:14.000Z","date":"2021-08-12","kind":"tax_withholding","acquired":false,"shares":702,"price":27.29,"value":19157.58,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 702 shares of Common Stock of the Company was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on October 16, 2019."}],"balance_after":28354,"source":{"system":"sec-edgar","filing":"0001567619-21-015950","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761921015950/doc1.xml","form_type":"4"}},{"id":2599653,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2021-08-17T10:48:14.000Z","date":"2021-08-12","kind":"exercise","acquired":true,"shares":2395,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This acquisition of  2,395 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. (the \"Company\"), represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on October 16, 2019."}],"balance_after":29056,"source":{"system":"sec-edgar","filing":"0001567619-21-015950","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761921015950/doc1.xml","form_type":"4"}},{"id":2623686,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2021-07-27T23:01:39.000Z","date":"2021-07-26","kind":"tax_withholding","acquired":false,"shares":318,"price":26.1,"value":8299.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 318 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 26, 2017."}],"balance_after":26661,"source":{"system":"sec-edgar","filing":"0001567619-21-014063","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761921014063/doc1.xml","form_type":"4"}},{"id":2625757,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-07-23T22:45:18.000Z","date":"2021-07-21","kind":"grant","acquired":true,"shares":11923,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These stock options vest in four equal annual installments beginning on July 21, 2022, such that 25% of the options will vest on each of July 21, 2022, 2023, 2024 and 2025."}],"balance_after":11923,"derivative":{"exercise_price":10.27,"exercise_date":"2022-07-21","expiration_date":"2031-07-21","underlying":"Common Stock","underlying_shares":11923},"source":{"system":"sec-edgar","filing":"0001567619-21-013920","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761921013920/doc1.xml","form_type":"4"}},{"id":2625756,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Performance Right","published_at":"2021-07-23T22:45:18.000Z","date":"2021-07-21","kind":"grant","acquired":true,"shares":8777,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."}],"balance_after":8777,"derivative":{"underlying":"Common Stock","underlying_shares":8777},"source":{"system":"sec-edgar","filing":"0001567619-21-013920","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761921013920/doc1.xml","form_type":"4"}},{"id":2625755,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2021-07-23T22:45:18.000Z","date":"2021-07-21","kind":"grant","acquired":true,"shares":4388,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The acquisition of 4,388 shares of Common Stock  of the Company represents 4,388 restricted stock units, each of which represents a contingent right to receive one share of Common Stock.  These restricted stock units vest in four equal annual installments beginning on July 21, 2022, such that 25% of the restricted stock units will vest on each of July 21, 2022, 2023, 2024 and 2025."}],"balance_after":26979,"source":{"system":"sec-edgar","filing":"0001567619-21-013920","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761921013920/doc1.xml","form_type":"4"}},{"id":2625754,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2021-07-23T22:45:18.000Z","date":"2021-07-18","kind":"tax_withholding","acquired":false,"shares":300,"price":24.76,"value":7428.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The exempt disposition of 300 shares of Common Stock of the Company was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 18, 2018."}],"balance_after":22591,"source":{"system":"sec-edgar","filing":"0001567619-21-013920","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761921013920/doc1.xml","form_type":"4"}},{"id":2625753,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2021-07-23T22:45:18.000Z","date":"2021-07-17","kind":"tax_withholding","acquired":false,"shares":262,"price":24.76,"value":6487.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 262 shares of Common Stock of the Company was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 17, 2019."}],"balance_after":22891,"source":{"system":"sec-edgar","filing":"0001567619-21-013920","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761921013920/doc1.xml","form_type":"4"}},{"id":2625752,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2021-07-23T22:45:18.000Z","date":"2021-07-14","kind":"tax_withholding","acquired":false,"shares":571,"price":26.43,"value":15091.53,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 571 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. (the \"Company\") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 14, 2020."}],"balance_after":23153,"source":{"system":"sec-edgar","filing":"0001567619-21-013920","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761921013920/doc1.xml","form_type":"4"}},{"id":3074723,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2020-07-28T20:27:12.000Z","date":"2020-07-27","kind":"tax_withholding","acquired":false,"shares":259,"price":8.8,"value":2279.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 259 shares of Common Stock was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 27, 2016."}],"balance_after":23724,"source":{"system":"sec-edgar","filing":"0001567619-20-013822","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761920013822/doc1.xml","form_type":"4"}},{"id":3074722,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2020-07-28T20:27:12.000Z","date":"2020-07-26","kind":"tax_withholding","acquired":false,"shares":283,"price":8.8,"value":2490.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 283 shares of common stock of AngioDynamics, Inc. (\"Common Stock\") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 26, 2017."}],"balance_after":23983,"source":{"system":"sec-edgar","filing":"0001567619-20-013822","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761920013822/doc1.xml","form_type":"4"}},{"id":3078613,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2020-07-21T23:31:15.000Z","date":"2020-07-18","kind":"tax_withholding","acquired":false,"shares":76,"price":9.21,"value":699.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"The exempt disposition of 76 shares of Common Stock was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 18, 2018."}],"balance_after":24266,"source":{"system":"sec-edgar","filing":"0001567619-20-013545","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761920013545/doc1.xml","form_type":"4"}},{"id":3078612,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2020-07-21T23:31:15.000Z","date":"2020-07-18","kind":"tax_withholding","acquired":false,"shares":224,"price":9.21,"value":2063.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 224 shares of Common Stock was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 18, 2018."}],"balance_after":24342,"source":{"system":"sec-edgar","filing":"0001567619-20-013545","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761920013545/doc1.xml","form_type":"4"}},{"id":3078611,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2020-07-21T23:31:15.000Z","date":"2020-07-17","kind":"tax_withholding","acquired":false,"shares":262,"price":9.46,"value":2478.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 262 shares of common stock of AngioDynamics, Inc. (\"Common Stock\") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 17, 2019."}],"balance_after":24566,"source":{"system":"sec-edgar","filing":"0001567619-20-013545","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761920013545/doc1.xml","form_type":"4"}},{"id":3080198,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-07-18T01:34:59.000Z","date":"2020-07-14","kind":"grant","acquired":true,"shares":19800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These stock options vest in four equal annual installments beginning on July 14, 2021, such that 25% of the options will vest on each of July 14, 2021, 2022, 2023 and 2024."}],"balance_after":19800,"derivative":{"exercise_price":9.92,"exercise_date":"2021-07-14","expiration_date":"2030-07-14","underlying":"Common Stock","underlying_shares":19800},"source":{"system":"sec-edgar","filing":"0001567619-20-013437","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761920013437/doc1.xml","form_type":"4"}},{"id":3080197,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Performance Right","published_at":"2020-07-18T01:34:59.000Z","date":"2020-07-14","kind":"grant","acquired":true,"shares":13453,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period in accordance with performance metrics as determined by the compensation committee. Any shares that do not vest at the end of the performance period will be forfeited."}],"balance_after":13453,"derivative":{"underlying":"Common Stock","underlying_shares":13453},"source":{"system":"sec-edgar","filing":"0001567619-20-013437","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761920013437/doc1.xml","form_type":"4"}},{"id":3080196,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2020-07-18T01:34:59.000Z","date":"2020-07-14","kind":"grant","acquired":true,"shares":6726,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This acquisition of 6,726 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. represents 6,726 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 14, 2021, such that 25% of the restricted stock units will vest on each of July 14, 2021, 2022, 2023 and 2024."}],"balance_after":24828,"source":{"system":"sec-edgar","filing":"0001567619-20-013437","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761920013437/doc1.xml","form_type":"4"}},{"id":3133335,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2020-05-28T00:56:06.000Z","date":"2020-05-23","kind":"tax_withholding","acquired":false,"shares":826,"price":11.21,"value":9259.46,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This exempt disposition of 826 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 27, 2016."}],"balance_after":18102,"source":{"system":"sec-edgar","filing":"0001567619-20-011253","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761920011253/doc1.xml","form_type":"4"}},{"id":3391002,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Performance Right","published_at":"2019-10-18T22:25:54.000Z","date":"2019-10-16","kind":"grant","acquired":true,"shares":6195,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each performance right represents a contingent right to receive one share of common stock (\"Common Stock\") of AngioDynamics, Inc. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based equally on revenue growth and adjusted earnings per share growth over a three-year performance period with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate). Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each performance right represents a contingent right to receive one share of common stock (\"Common Stock\") of AngioDynamics, Inc. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based equally on revenue growth and adjusted earnings per share growth over a three-year performance period with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate). Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each performance right represents a contingent right to receive one share of common stock (\"Common Stock\") of AngioDynamics, Inc. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based equally on revenue growth and adjusted earnings per share growth over a three-year performance period with a potential upward or downward 20% adjustment on the calculated achievement based on total shareholder return relative to a peer group of companies over a three-year performance period (for a total potential payout of up to 240% of the target number in the aggregate). Any shares that do not vest at the end of the performance period will be forfeited."}],"balance_after":6195,"derivative":{"underlying":"Common Stock","underlying_shares":6195},"source":{"system":"sec-edgar","filing":"0001567619-19-019769","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761919019769/doc1.xml","form_type":"4"}},{"id":3434154,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Performance right","published_at":"2019-08-20T01:58:02.000Z","date":"2019-07-12","kind":"exercise","acquired":false,"shares":6103,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"On July 27, 2016, the reporting person received a target grant of 6,103 performance share units vesting between 0% and 200%.  The performance of this award was based on the Company's total shareholder return relative to a peer group of companies over a three-year period covering the Company's fiscal years 2017, 2018 and 2019.  Based on the Company's performance over this period, 3,174 shares of Common Stock were issued to the reporting person under this grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On July 27, 2016, the reporting person received a target grant of 6,103 performance share units vesting between 0% and 200%.  The performance of this award was based on the Company's total shareholder return relative to a peer group of companies over a three-year period covering the Company's fiscal years 2017, 2018 and 2019.  Based on the Company's performance over this period, 3,174 shares of Common Stock were issued to the reporting person under this grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On July 27, 2016, the reporting person received a target grant of 6,103 performance share units vesting between 0% and 200%.  The performance of this award was based on the Company's total shareholder return relative to a peer group of companies over a three-year period covering the Company's fiscal years 2017, 2018 and 2019.  Based on the Company's performance over this period, 3,174 shares of Common Stock were issued to the reporting person under this grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6103},"source":{"system":"sec-edgar","filing":"0001567619-19-017315","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761919017315/doc1.xml","form_type":"4"}},{"id":3434153,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2019-08-20T01:58:02.000Z","date":"2019-07-12","kind":"tax_withholding","acquired":false,"shares":1050,"price":21.68,"value":22764.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 1,050 shares of Common Stock of the Company was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 27, 2016."}],"balance_after":21052,"source":{"system":"sec-edgar","filing":"0001567619-19-017315","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761919017315/doc1.xml","form_type":"4"}},{"id":3434152,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2019-08-20T01:58:02.000Z","date":"2019-07-12","kind":"exercise","acquired":true,"shares":3174,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This acquisition of 3,174 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. (the \"Company\"), represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 27, 2016."}],"balance_after":22102,"source":{"system":"sec-edgar","filing":"0001567619-19-017315","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761919017315/doc1.xml","form_type":"4"}},{"id":3448909,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2019-08-02T20:31:28.000Z","date":"2019-07-27","kind":"tax_withholding","acquired":false,"shares":252,"price":20.91,"value":5269.32,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 252 shares of Common Stock was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 27, 2016."}],"balance_after":18928,"source":{"system":"sec-edgar","filing":"0001567619-19-015722","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761919015722/doc1.xml","form_type":"4"}},{"id":3448908,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2019-08-02T20:31:28.000Z","date":"2019-07-26","kind":"tax_withholding","acquired":false,"shares":276,"price":20.89,"value":5765.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 276 shares of common stock of AngioDynamics, Inc. (\"Common Stock\") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 26, 2017."}],"balance_after":19180,"source":{"system":"sec-edgar","filing":"0001567619-19-015722","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761919015722/doc1.xml","form_type":"4"}},{"id":3455976,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2019-07-25T20:54:20.000Z","date":"2019-07-18","kind":"tax_withholding","acquired":false,"shares":74,"price":21.53,"value":1593.22,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 74 shares of Common Stock was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 18, 2018."}],"balance_after":19456,"source":{"system":"sec-edgar","filing":"0001567619-19-015207","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761919015207/doc1.xml","form_type":"4"}},{"id":3455975,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2019-07-25T20:54:20.000Z","date":"2019-07-18","kind":"tax_withholding","acquired":false,"shares":218,"price":21.53,"value":4693.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 218 shares of common stock of AngioDynamics, Inc. (\"Common Stock\") was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 18, 2018."}],"balance_after":19530,"source":{"system":"sec-edgar","filing":"0001567619-19-015207","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761919015207/doc1.xml","form_type":"4"}},{"id":3458427,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-07-20T01:38:49.000Z","date":"2019-07-17","kind":"grant","acquired":true,"shares":10361,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These stock options vest in four equal annual installments beginning on July 17, 2020, such that 25% of the options will vest on each of July 17, 2020, 2021, 2022 and 2023."}],"balance_after":10361,"derivative":{"exercise_price":21.54,"exercise_date":"2020-07-17","expiration_date":"2029-07-17","underlying":"Common Stock","underlying_shares":10361},"source":{"system":"sec-edgar","filing":"0001567619-19-015051","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761919015051/doc1.xml","form_type":"4"}},{"id":3458426,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2019-07-20T01:38:49.000Z","date":"2019-07-17","kind":"grant","acquired":true,"shares":3098,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This acquisition of 3,098 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. represents 3,098 restricted stock units, each of which represents a contingent right to receive one share of Common Stock.  These restricted stock units vest in four equal annual installments beginning on July 17, 2020, such that 25% of the restricted stock units will vest on each of July 17, 2020, 2021, 2022 and 2023."}],"balance_after":19748,"source":{"system":"sec-edgar","filing":"0001567619-19-015051","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761919015051/doc1.xml","form_type":"4"}},{"id":3511479,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2019-05-24T16:53:33.000Z","date":"2019-05-23","kind":"tax_withholding","acquired":false,"shares":858,"price":19.15,"value":16430.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 858 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 27, 2016."}],"balance_after":16650,"source":{"system":"sec-edgar","filing":"0001567619-19-012041","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000156761919012041/doc1.xml","form_type":"4"}},{"id":3858919,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2018-07-30T22:53:07.000Z","date":"2018-07-27","kind":"tax_withholding","acquired":false,"shares":252,"price":21.42,"value":5397.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 252 shares of Common Stock was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 27, 2016."}],"balance_after":17508,"source":{"system":"sec-edgar","filing":"0001140361-18-034272","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036118034272/doc1.xml","form_type":"4"}},{"id":3859849,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2018-07-28T00:08:46.000Z","date":"2018-07-26","kind":"tax_withholding","acquired":false,"shares":276,"price":21.88,"value":6038.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 276 shares of Common Stock was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 26, 2017."}],"balance_after":17760,"source":{"system":"sec-edgar","filing":"0001140361-18-033947","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036118033947/doc1.xml","form_type":"4"}},{"id":3863502,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Performance Right","published_at":"2018-07-21T01:34:56.000Z","date":"2018-07-18","kind":"grant","acquired":true,"shares":7079,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period ending May 31, 2021. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period ending May 31, 2021. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period ending May 31, 2021. Any shares that do not vest at the end of the performance period will be forfeited."}],"balance_after":7079,"derivative":{"underlying":"Common Stock","underlying_shares":7079},"source":{"system":"sec-edgar","filing":"0001140361-18-033091","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036118033091/doc1.xml","form_type":"4"}},{"id":3863501,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2018-07-21T01:34:56.000Z","date":"2018-07-18","kind":"grant","acquired":true,"shares":11276,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These stock options vest in four equal annual installments beginning on July 18, 2019, such that 25% of the options will vest on each of July 18, 2019, 2020, 2021 and 2022."}],"balance_after":11276,"derivative":{"exercise_price":20.93,"exercise_date":"2019-07-18","expiration_date":"2028-07-18","underlying":"Common Stock","underlying_shares":11276},"source":{"system":"sec-edgar","filing":"0001140361-18-033091","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036118033091/doc1.xml","form_type":"4"}},{"id":3863500,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2018-07-21T01:34:56.000Z","date":"2018-07-18","kind":"grant","acquired":true,"shares":3539,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This acquisition of 3,539 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. represents 3,539 restricted stock units, each of which represents a contingent right to receive one share of Common Stock.  These restricted stock units vest in four equal annual installments beginning on July 18, 2019, such that 25% of the restricted stock units will vest on each of July 18, 2019, 2020, 2021 and 2022."}],"balance_after":18036,"source":{"system":"sec-edgar","filing":"0001140361-18-033091","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036118033091/doc1.xml","form_type":"4"}},{"id":3918315,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2018-05-25T00:58:03.000Z","date":"2018-05-23","kind":"tax_withholding","acquired":false,"shares":827,"price":20.37,"value":16845.99,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 827 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 27, 2016."}],"balance_after":14497,"source":{"system":"sec-edgar","filing":"0001140361-18-025601","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036118025601/doc1.xml","form_type":"4"}},{"id":4249287,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Performance Right","published_at":"2017-07-28T21:35:29.000Z","date":"2017-07-26","kind":"grant","acquired":true,"shares":6684,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period ending May 31, 2020. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period ending May 31, 2020. Any shares that do not vest at the end of the performance period will be forfeited."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period ending May 31, 2020. Any shares that do not vest at the end of the performance period will be forfeited."}],"balance_after":6684,"derivative":{"underlying":"Common Stock","underlying_shares":6684},"source":{"system":"sec-edgar","filing":"0001140361-17-029177","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036117029177/doc1.xml","form_type":"4"}},{"id":4249286,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2017-07-28T21:35:29.000Z","date":"2017-07-26","kind":"grant","acquired":true,"shares":11744,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These stock options vest in four equal annual installments beginning on July 26, 2018, such that 25% of the options will vest on each of July 26, 2018, 2019, 2020 and 2021."}],"balance_after":11744,"derivative":{"exercise_price":16.55,"exercise_date":"2018-07-26","expiration_date":"2027-07-26","underlying":"Common Stock","underlying_shares":11744},"source":{"system":"sec-edgar","filing":"0001140361-17-029177","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036117029177/doc1.xml","form_type":"4"}},{"id":4249285,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2017-07-28T21:35:29.000Z","date":"2017-07-27","kind":"tax_withholding","acquired":false,"shares":282,"price":16.36,"value":4613.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"The exempt disposition of 282 shares of Common Stock was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 27, 2016."}],"balance_after":15324,"source":{"system":"sec-edgar","filing":"0001140361-17-029177","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036117029177/doc1.xml","form_type":"4"}},{"id":4249284,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2017-07-28T21:35:29.000Z","date":"2017-07-26","kind":"grant","acquired":true,"shares":3342,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This acquisition of 3,342 shares of common stock (\"Common Stock\") of AngioDynamics, Inc. represents 3,342 restricted stock units, each of which represents a contingent right to receive one share of Common Stock.  These restricted stock units vest in four equal annual installments beginning on July 26, 2018, such that 25% of the restricted stock units will vest on each of July 26, 2018, 2019, 2020 and 2021."}],"balance_after":15606,"source":{"system":"sec-edgar","filing":"0001140361-17-029177","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036117029177/doc1.xml","form_type":"4"}},{"id":4304453,"issuer":{"id":5275,"kind":"organization","name":"ANGIODYNAMICS INC"},"owners":[{"id":28737,"kind":"person","name":"Campbell Chad Thomas","position":1,"cik":"0001706852","reported_name":"Campbell Chad Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP/GM, Vascular Access"}}],"security":"Common Stock","published_at":"2017-05-25T22:07:39.000Z","date":"2017-05-23","kind":"tax_withholding","acquired":false,"shares":788,"price":15.82,"value":12466.16,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The exempt disposition of 788 shares of common stock of AngioDynamics, Inc. was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying restricted stock units granted to the reporting person on July 27, 2016."}],"balance_after":12264,"source":{"system":"sec-edgar","filing":"0001140361-17-022413","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1275187/000114036117022413/doc1.xml","form_type":"4"}}]}